Cooley’s 2021 Life Sciences M&A Year in Review
Cooley M&A
JANUARY 20, 2022
Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. 2] Examples of this strategy coming to bear in 2021 included Thermo Fisher Scientific’s acquisition of PPD for $17.4 driven assets. term average of approximately 35%.
Let's personalize your content